Review article: Recommendations for the clinical management of patients taking non-steroidal anti-inflammatory drugs - A gastroenterologist's perspective

Alimentary Pharmacology and Therapeutics Symposium Series

Volumn 1, Issue 1, 2005, Pages 16-19

  Lanas, A ^a,b  

^a INSTITUTO ARAGONÉS DE CIENCIAS DE LA SALUD   (Spain)

^b UNIVERSITY OF ZARAGOZA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CALCIUM CHANNEL BLOCKING AGENT; CELECOXIB; CLOPIDOGREL; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; IBUPROFEN; LUMIRACOXIB; MELOXICAM; MISOPROSTOL; NITRATE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PLACEBO; PROTON PUMP INHIBITOR; ROFECOXIB; STOMACH SECRETION INHIBITOR; TICLOPIDINE; VALDECOXIB;

ANALGESIA; CLINICAL TRIAL; COLON POLYP; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DIGESTIVE SYSTEM ULCER; DRUG ANTAGONISM; DRUG EFFICACY; DRUG FATALITY; DRUG POTENTIATION; DRUG SAFETY; DYSPEPSIA; GASTROINTESTINAL HEMORRHAGE; HELICOBACTER INFECTION; HOSPITALIZATION; HUMAN; LOW DRUG DOSE; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR;

EID: 26044475012     PISSN: 17466334     EISSN: 17466342     Source Type: Journal    
DOI: 10.1111/j.1746-6342.2005.00015.x     Document Type: Conference Paper

References (15)

1. Lanas A, Fuentes J, Benito R, Serrano P, Bajador E, Sainz R. Helicobacter pylori increases the risk of upper gastrointestinal bleeding in patients taking low-dose aspirin. Aliment Pharmacol Ther 2002; 16: 779-86.
2. Baron JA, Cole BF, Sandler RS, et al. A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med 2003; 348: 891-9.
3. Lanas A, Pere-Aisa MA, Feu F, et al. A nationwide study of mortality associated with non-steroidal anti-inflammatory drug use. Am J Gastroenterol. In press.
4. Blower AL, Brooks A, Fenn GC, et al. Emergency admissions for upper gastrointestinal disease and their relation to NSAID use. Aliment Pharmacol Ther 1997; 11: 283-91.
5. Wolfe MM, Lichtenstein DR, Singh G. Gastrointestinal toxicity of nonsteroidal anti-inflammatory drugs. N Engl J Med 1999; 340: 1888-99.
6. Perez-Aisa MA, Del Pino D, Sues M, Lanas A. Clinical trends in ulcer diagnosis in a population with high prevalence of Helicobacter pylori infection. Aliment Pharmacol Ther 2005; 1: 65-72.
7. Bombardier C, Laine L, Reicin A, et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med 2000; 343: 1520-8.
8. Silverstein FE, Faich G, Goldstein JL, et al. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. J Am Med Assoc 2000; 284: 1247-55.
9. Hawkey CJ, Skelly MM. Gastrointestinal safety of selective COX-2 inhibitors. Curr Pharm Des 2002; 8: 1077-89.
10. Schnitzer TJ, Burmester GR, Mysler E, et al. Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial. Lancet 2004; 364: 675-84.
11. Lanas A, Garcia-Rodriguez A, Arroyo M-T, et al. Coxibs, NSAIDs aspirin, PPIs and the risk of upper GI bleeding in common clinical practice. Gastroenterology 2005; 128 (Suppl. 2): A-95, abstract 629.
12. Lanas A. The appropriate use of proton-pump inhibitor cotherapy with non-steroidal anti-inflammatory drugs and cyclo-oxygenase-2 selective inhibitors. Aliment Pharmacol Ther 2005; 21 (Suppl. 1): 2-4.
13. Bresalier RS, Sandler RS, Quan H, et al. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med 2005; 352: 1092-102.
14. Ekstrom P, Carling L, Wetterhus S, et al. Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy. A Nordic multicentre study. Scand J Gastroenterol 1996; 31: 753-8.
15. Cullen D, Bardhan KD, Eisner M, et al. Primary gastroduodenal prophylaxis with omeprazole for non-steroidal anti-inflammatory drug users. Aliment Pharmacol Ther 1998; 12: 135-40.